GORRY, Philippe

doi:10.1142/9789811262739_0009

Metadatos

Mostrar el registro completo del ítem

Licencia de uso del documento

GORRY, Philippe

Bordeaux Sciences Economiques [BSE]

Idioma

Chapitre d'ouvrage

Este ítem está publicado en

Flattening the Curve: COVID-19 & Grand Challenges for Global Health, Innovation, and Economy. 2023-06p. 237-265

World Scientific Publishing

Resumen en inglés

With the COVID-19 pandemic, governments around the globe discovered the vulnerability of the pharma supply chains (PSCs). In this review, we describe the nature of disruptions that occurred and the political debates. Then, we examine some features of the demand in pharmaceuticals: the evolution of the health market, drug supply shortages, and the access to essential medicines. After some reminders about the organization of the pharmaceutical industry and drug manufacturing, we analyze the characteristics of the supply of pharmaceuticals and the trends of the pharma globalization value chain (GVC). Finally, we discuss policy proposals to circumvent the disruption of PSCs in times of crisis, including stockpiling, improving the resilience of the PSCs, protecting the industrial commons, and relocating manufacturing plants. In conclusion, we draw a research agenda for economists and a political agenda for governments.< Leer menos

Palabras clave en inglés

COVID-19

Global value chain

Supply chain

pharmaceuticals

Drug shortage

Metadatos

Compartir este ítem

Licencia de uso del documento

Pharma Supply Chain and Globalization in the Face of the COVID-19 Pandemic: A Review

Idioma

Este ítem está publicado en

Resumen en inglés

Palabras clave en inglés

URI

DOI

Centros de investigación